1985
DOI: 10.1007/bf00437284
|View full text |Cite
|
Sign up to set email alerts
|

Use of enzyme-linked immunosorbent assay for the diagnosis of equine Histoplasmosis farciminosi (epizootic lymphangitis)

Abstract: An enzyme-linked immunosorbent assay was evaluated for the detection of antibody in sera of equine naturally infected with Histoplasma farciminosum 'epizootic lymphangitis'. Ten sera from naturally infected horses were tested. A hydrogen peroxide ABTS mixture constituted the substrate. The reactions were read as the absorbance values measured at 405 nm using a spectrophotometer. The standard deviation and the average percentage of the absorbance values of the different serum samples were considered in the inte… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1989
1989
2015
2015

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 8 publications
0
1
0
Order By: Relevance
“…The respiratory form is characterised by pyo-granulomatous lesions within the nasal mucosa that can extend throughout the respiratory tract to the lung parenchyma Fawi, 1971;Al-Ani, 1999). Few studies have examined the equine immune response to Histoplasma and the extent and duration of immunity to natural infection, the presence of asymptomatic carriers and response to experimental vaccination are yet to be fully ascertained (Noskoav, 1960;Gabal and Khalifa, 1983;Soliman et al, 1984;Gabal and Mohammed, 1985;Soliman et al, 1985;Zhang et al, 1986;Ameni et al, 2006).…”
Section: Introductionmentioning
confidence: 94%
“…The respiratory form is characterised by pyo-granulomatous lesions within the nasal mucosa that can extend throughout the respiratory tract to the lung parenchyma Fawi, 1971;Al-Ani, 1999). Few studies have examined the equine immune response to Histoplasma and the extent and duration of immunity to natural infection, the presence of asymptomatic carriers and response to experimental vaccination are yet to be fully ascertained (Noskoav, 1960;Gabal and Khalifa, 1983;Soliman et al, 1984;Gabal and Mohammed, 1985;Soliman et al, 1985;Zhang et al, 1986;Ameni et al, 2006).…”
Section: Introductionmentioning
confidence: 94%